Table 2 Macro and microvascular and metabolic complications of patients with idiopathic and autoimmune type 1 diabetes mellitus at onset, after metabolic stabilization
|  | Idiopathic type 1 diabetes (N = 30) | Autoimmune type 1 diabetes (N = 30) | p* |
|---|---|---|---|
Subjects (%) | Subjects (%) | ||
Family history of type 2 diabetes | 12 (40%) | 9 (30%) | 0.430 |
Macrovascular complications | |||
 Arterial hypertension | 2 (6%) | 4 (13%) | 0.389 |
 Coronary heart disease | 0 | 0 | / |
 Peripheral vascular disease | 0 | 0 | / |
 Cerebral vascular disease | 0 | 0 | / |
Microvascular complications | |||
 Diabetic retinopathy | 2 (6%) | 0 | 0.150 |
 Diabetic nephropathy | 2 (6%) | 4 (13%) | 0.389 |
 Diabetic neuropathy | 2 (6%) | 0 | 0.150 |
Metabolic complications | |||
 Hepatic steatosis | 9 (30%) | 0 | 0.001 |
 Visceral obesity | 15 (50%) | 7 (23%) | 0.032 |
 Hypercholesterolemia | 16 (53%) | 6 (20%) | 0.007 |